The pharmacokinetics of levetiracetam in healthy dogs concurrently receiving phenobarbital

Journal of Veterinary Pharmacology and Therapeutics

Volumn 34, Issue 1, 2011, Pages 31-34

  Moore, S ^a   Munana K R ^a   Papich, M G ^a   Nettifee Osborne, J A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; PHENOBARBITAL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; COMPARTMENT MODEL; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; EPILEPSY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; STEADY STATE; TREATMENT DURATION;

ABSORPTION; ANIMALS; ANTICONVULSANTS; AREA UNDER CURVE; DOGS; DRUG INTERACTIONS; HALF-LIFE; PHENOBARBITAL; PIRACETAM;

CANIS FAMILIARIS;

EID: 78651225273     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2010.01188.x     Document Type: Article

References (12)

1. Benedetti, M.S., Coupez, R., Whomsley, R., Nicolas, J.M., Collart, P. & Baltes, E. (2004) Comparative pharmacokinetics and metabolism of levetiracetam, a new anti-epileptic agent, in mouse, rat, rabbit, and dog. Xenobiotica, 34, 281-300.
2. Gidal, B.E., Baltes, E., Otoul, C. & Perucca, E. (2005) Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials. Epilepsy Research, 64, 1-11.
3. Hirsch, L.J., Arif, H., Buchsbaum, R., Weintraub, D., Lee, J., Chang, J.T., Resor, S.R. Jr & Bazil, C.W. (2007) Effect of age and comedication on levetiracetam pharmacokinetics and tolerability. Epilepsia, 48, 1351-1359.
4. Hojo, T., Ohno, R., Shimoda, M. & Kokue, E. (2002) Enzyme and plasma protein induction by multiple oral administrations of Phenobarbital at a therapeutic dosage regimen in dogs. Journal of Veterinary Pharmacology and Therapeutics, 25, 121-127.
5. Isoherranen, N., Yagen, B., Soback, S., Roeder, M., Schurig, V. & Bialer, M. (2001) Pharmacokinetics of levetiracetam and its enantiomer (R)-α-ethyl-2-oxo-pyrrolidine acetamide in dogs. Epilepsia, 42, 825-830.
6. Levitski, R.E. & Trepanier, L.A. (2000) Effect of timing of blood collection on serum phenobarbital concentrations in dogs with epilepsy. Journal of the American Veterinary Medical Association, 217, 200-204.
7. Moore, S.A., Munana, K.R., Papich, M.G. & Nettifee-Osborne, J. (2010). The Pharmacokinetics of oral levetiracetam in the dog following single and repeated oral dosing. American Journal of Veterinary Research, 71, 337-341.
8. Nicolas, J.M., Collart, R., Gerin, B., Mather, G., Trager, W., Levy, R. & Roba, J. (1999) In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent. Drug Metabolism and Disposition, 27, 250-254.
9. Patterson, E.E., Goel, V., Cloyd, J.C., O'Brien, T.D., Fisher, J.E., Dunn, A.W. & Leppik, I.E. (2008) Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics, 31, 253-258.
10. Perucca, E., Gidal, B.E. & Baltes, E. (2003) Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials. Epilepsy Research, 53, 47-56.
11. Podell, M., Fenner, W.R. & Powers, J.D. (1995) Seizure classification in dogs from a nonreferral-based population. Journal of the American Veterinary Medical Association, 206, 1721-1728.
12. Schwartz-Porsche, D., Loscher, W. & Frey, H.H. (1985) Therapeutic efficacy of Phenobarbital and primidone in canine epilepsy: a comparison. Journal of Veterinary Pharmacology and Therapeutics, 8, 113-119.